Better screening needed for sickle cell and thalassaemiaBMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7256.262/e (Published 29 July 2000) Cite this as: BMJ 2000;321:262
- Jenny Blythe
Universal antenatal screening for sickle cell disease and thalassaemia may be cost effective in some areas of the United Kingdom, says a report from the Wessex Institute for Health Research and Development.
Universal antenatal and neonatal screening was previously recommended in areas in which 15% or more of the population are from ethnic minority groups. Current screening models are in operation, but the institute describes the service as “patchy” and “unstructured.” According …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial